Keywords: Alvogen, Kunwha Pharma, Alliance Pharma, Opus Group, M&A

Alvogen to acquire majority stake in Kunwha Pharma; Alliance buys Opus

Article | 21 October 2012

Print This

Privately-held US drugmaker Alvogen last Friday entered into an agreement to acquire a majority share in South Korea-based generic drugs ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in